REQUEST A DEMO
Total
USD $0.00
Search more companies

Genmedica Baltic SIA (Latvia)

Main Activities: Other Chemical and Allied Products Merchant Wholesalers
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Genmedica Baltic SIA Profile Updated: March 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Genmedica Baltic SIA is an enterprise based in Latvia. Its main office is in Riga. The company operates in the Other Chemical and Allied Products Merchant Wholesalers sector. The enterprise was incorporated on January 14, 2014. Genmedica Baltic SIA currently employs 7 (2023) people. The latest financial highlights indicate a net sales revenue drop of 5.78% in 2024. A growth of 3.45% was recorded in its total assets. Genmedica Baltic SIA’s net profit margin decreased by 2.43% in 2024.

Headquarters
Miera iela 43 - 3
Riga; Riga; Postal Code: 1001

Contact Details: Purchase the Genmedica Baltic SIA report to view the information.

Basic Information
Total Employees:
Purchase the Genmedica Baltic SIA report to view the information.
Registered Capital:
Purchase the Genmedica Baltic SIA report to view the information.
Financial Auditors:
Purchase the Genmedica Baltic SIA report to view the information.
Incorporation Date:
January 14, 2014
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Realto Daryo SIA
50%
Company Performance
Financial values in the chart are available after Genmedica Baltic SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-5.78%
Total Operating Revenue
-4.36%
Operating Profit
-58.1%
EBITDA
-58.1%
Net Profit/Loss for the Period
-54.32%
Total Assets
3.45%
Total Equity
1.54%
Operating Profit Margin
-2.78%
Net Profit Margin
-2.43%
Return on Equity (ROE)
-2.12%
Quick Ratio
-0.92%
Cash Ratio
0.67%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?